Literature DB >> 30828968

Granzyme B Functionalized Nanoparticles Targeting Membrane Hsp70-Positive Tumors for Multimodal Cancer Theranostics.

Maxim Shevtsov1,2,3,4, Stefan Stangl1, Boris Nikolaev5, Ludmila Yakovleva5, Yaroslav Marchenko5, Ruslana Tagaeva5, Wolfgang Sievert1, Emil Pitkin6, Anton Mazur7, Peter Tolstoy7, Oleg Galibin3, Vyacheslav Ryzhov8, Katja Steiger9, Oleg Smirnov8, William Khachatryan4, Kerry Chester10, Gabriele Multhoff1.   

Abstract

Functionalized superparamagnetic iron oxide nanoparticles (SPIONs) have emerged as potential clinical tools for cancer theranostics. Membrane-bound 70 kDa heat shock protein (mHsp70) is ubiquitously expressed on the cell membrane of various tumor types but not normal cells and therefore provides a tumor-specific target. The serine protease granzyme B (GrB) that is produced as an effector molecule by activated T and NK cells has been shown to specifically target mHsp70 on tumor cells. Following binding to Hsp70, GrB is rapidly internalized into tumor cells. Herein, it is demonstrated that GrB functionalized SPIONs act as a contrast enhancement agent for magnetic resonance imaging and induce specific tumor cell apoptosis. Combinatorial regimens employing stereotactic radiotherapy and/or magnetic targeting are found to further enhance the therapeutic efficacy of GrB-SPIONs in different tumor mouse models.
© 2019 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  glioblastoma; granzyme B; magnetic targeting; radiotherapy; superparamagnetic nanoparticles

Year:  2019        PMID: 30828968     DOI: 10.1002/smll.201900205

Source DB:  PubMed          Journal:  Small        ISSN: 1613-6810            Impact factor:   13.281


  10 in total

1.  A New Pharmacokinetic Model Describing the Biodistribution of Intravenously and Intratumorally Administered Superparamagnetic Iron Oxide Nanoparticles (SPIONs) in a GL261 Xenograft Glioblastoma Model.

Authors:  Alexander P Klapproth; Maxim Shevtsov; Stefan Stangl; Wei Bo Li; Gabriele Multhoff
Journal:  Int J Nanomedicine       Date:  2020-06-30

Review 2.  Recent development of contrast agents for magnetic resonance and multimodal imaging of glioblastoma.

Authors:  Danping Zhuang; Huifen Zhang; Genwen Hu; Bing Guo
Journal:  J Nanobiotechnology       Date:  2022-06-16       Impact factor: 9.429

Review 3.  Membrane-Associated Heat Shock Proteins in Oncology: From Basic Research to New Theranostic Targets.

Authors:  Maxim Shevtsov; Zsolt Balogi; William Khachatryan; Huile Gao; László Vígh; Gabriele Multhoff
Journal:  Cells       Date:  2020-05-20       Impact factor: 6.600

4.  Gold Nanoparticle Mediated Multi-Modal CT Imaging of Hsp70 Membrane-Positive Tumors.

Authors:  Melanie A Kimm; Maxim Shevtsov; Caroline Werner; Wolfgang Sievert; Wu Zhiyuan; Oliver Schoppe; Bjoern H Menze; Ernst J Rummeny; Roland Proksa; Olga Bystrova; Marina Martynova; Gabriele Multhoff; Stefan Stangl
Journal:  Cancers (Basel)       Date:  2020-05-22       Impact factor: 6.639

5.  A novel Granzyme B nanoparticle delivery system simulates immune cell functions for suppression of solid tumors.

Authors:  Xiaomin Qian; Zhendong Shi; Hongzhao Qi; Ming Zhao; Kai Huang; Donglin Han; Junhu Zhou; Chaoyong Liu; Yang Liu; Yunfeng Lu; Xubo Yuan; Jin Zhao; Chunsheng Kang
Journal:  Theranostics       Date:  2019-10-14       Impact factor: 11.556

Review 6.  Magnetic nanoparticles in theranostics of malignant melanoma.

Authors:  Maxim Shevtsov; Susanne Kaesler; Christian Posch; Gabriele Multhoff; Tilo Biedermann
Journal:  EJNMMI Res       Date:  2021-12-14       Impact factor: 3.138

7.  Potential Role of Hsp70 and Activated NK Cells for Prediction of Prognosis in Glioblastoma Patients.

Authors:  Dominik Lobinger; Jens Gempt; Wolfgang Sievert; Melanie Barz; Sven Schmitt; Huyen Thie Nguyen; Stefan Stangl; Caroline Werner; Fei Wang; Zhiyuan Wu; Hengyi Fan; Hannah Zanth; Maxim Shevtsov; Mathias Pilz; Isabelle Riederer; Melissa Schwab; Jürgen Schlegel; Gabriele Multhoff
Journal:  Front Mol Biosci       Date:  2021-05-17

Review 8.  Nanoparticles as immunomodulators and translational agents in brain tumors.

Authors:  Adam J Grippin; Kyle A Dyson; Sadeem Qdaisat; James McGuiness; Brandon Wummer; Duane A Mitchell; Hector R Mendez-Gomez; Elias J Sayour
Journal:  J Neurooncol       Date:  2020-08-05       Impact factor: 4.130

Review 9.  Bio-Nanocarriers for Lung Cancer Management: Befriending the Barriers.

Authors:  Shruti Rawal; Mayur Patel
Journal:  Nanomicro Lett       Date:  2021-06-12

Review 10.  Combination of Anti-Cancer Drugs with Molecular Chaperone Inhibitors.

Authors:  Maxim Shevtsov; Gabriele Multhoff; Elena Mikhaylova; Atsushi Shibata; Irina Guzhova; Boris Margulis
Journal:  Int J Mol Sci       Date:  2019-10-24       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.